FIELD: medicine. SUBSTANCE: method involves carrying out ciliary body endolaser coagulation to fix it to sclera at two nearest points. The ciliary body is transected with erbium-YAG endolaser. EFFECT: reliable reduction of intraocular pressure; reduced risk of ciliary body detachment and secondary glaucoma recurrence.
Authors
Dates
2001-03-20—Published
1999-02-15—Filed